Pharmaceutical Commerce - August 2022 Issue (PDF)

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.

The President plans to sign an executive order on Monday morning to enforce the trade clause.